Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fay

Showing results (311-320 of 395) with videos related to

Pageof 40
Sort By:
Scientific Reports|September 17, 2015
Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malariaDavid Llewellyn, Kazutoyo Miura, Michael P Fay, et al.
The Lancet. Infectious Diseases|January 18, 2016
Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort studyChanaki Amaratunga, Pharath Lim, Seila Suon, et al.
Cancer Immunology Research|May 28, 2015
Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell CarcinomaMarcella Callea, Laurence Albiges, Mamta Gupta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2010
Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levelsBenoit Dembele, Yaya I Coulibaly, Housseini Dolo, et al.
Journal for Immunotherapy of Cancer|March 14, 2015
Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker studyAndré P Fay, Sabina Signoretti, Marcella Callea, et al.
European Urology Oncology|June 12, 2024
Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination TherapyNeal D Shore, Michael S Broder, Pedro C Barata, et al.
Plos Neglected Tropical Diseases|November 8, 2012
Filariasis attenuates anemia and proinflammatory responses associated with clinical malaria: a matched prospective study in children and young adultsHousseini Dolo, Yaya I Coulibaly, Benoit Dembele, et al.
Plos One|January 26, 2013
A potential role for plasma uric acid in the endothelial pathology of Plasmodium falciparum malariaNeida K Mita-Mendoza, Diana L van de Hoef, Tatiana M Lopera-Mesa, et al.
Cancer|November 6, 2015
Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumMarina D Kaymakcalan, Wanling Xie, Laurence Albiges, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2020
Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinomaYohann Loriot, Cora N Sternberg, Daniel Castellano, et al.
Pageof 40

Showing results (311-320 of 395) with videos related to

Sort By:
Pageof 40
Scientific Reports|September 17, 2015
Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malariaDavid Llewellyn, Kazutoyo Miura, Michael P Fay, et al.
The Lancet. Infectious Diseases|January 18, 2016
Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort studyChanaki Amaratunga, Pharath Lim, Seila Suon, et al.
Cancer Immunology Research|May 28, 2015
Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell CarcinomaMarcella Callea, Laurence Albiges, Mamta Gupta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2010
Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levelsBenoit Dembele, Yaya I Coulibaly, Housseini Dolo, et al.
Journal for Immunotherapy of Cancer|March 14, 2015
Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker studyAndré P Fay, Sabina Signoretti, Marcella Callea, et al.
European Urology Oncology|June 12, 2024
Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination TherapyNeal D Shore, Michael S Broder, Pedro C Barata, et al.
Plos Neglected Tropical Diseases|November 8, 2012
Filariasis attenuates anemia and proinflammatory responses associated with clinical malaria: a matched prospective study in children and young adultsHousseini Dolo, Yaya I Coulibaly, Benoit Dembele, et al.
Plos One|January 26, 2013
A potential role for plasma uric acid in the endothelial pathology of Plasmodium falciparum malariaNeida K Mita-Mendoza, Diana L van de Hoef, Tatiana M Lopera-Mesa, et al.
Cancer|November 6, 2015
Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumMarina D Kaymakcalan, Wanling Xie, Laurence Albiges, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2020
Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinomaYohann Loriot, Cora N Sternberg, Daniel Castellano, et al.
Pageof 40